Sidra Naz | Cancer Biophotonics Studies | Best Researcher Award

Dr. Sidra Naz | Cancer Biophotonics Studies | Best Researcher Award

Research Fellow at University of Texas MD Anderson Cancer Center, United States

Dr. Sidra Naz is a dedicated physician-scientist known for her groundbreaking research in the fields of clinical medicine, public health, and epidemiology. With a strong background in medical education and research, she has contributed significantly to advancing medical knowledge through her extensive publications and collaborative projects. Dr. Naz is passionate about improving healthcare outcomes, particularly in oncology, cardiology, and neurology. Her commitment to medical research and patient care has earned her numerous accolades and recognition in the scientific community.

Profile

Google Scholar

Education ๐ŸŽ“

Dr. Naz completed her M.B.B.S. at Faisalabad Medical University, Pakistan, in 2017, laying the foundation for her medical expertise. She further pursued a Master of Public Health in Epidemiology at Ohio University, USA, where she honed her skills in public health research. Her continuous pursuit of knowledge has led her to collaborate with renowned institutions, enriching her understanding of complex medical conditions and their global impact.

Experience ๐ŸŒŸ

Dr. Naz has amassed a wealth of experience through her roles at prestigious medical institutions. She currently serves as a Clinical Research Associate and Research Coordinator at the University of Texas MD Anderson Cancer Center, where she focuses on oncology research. Previously, she held a postdoctoral research fellowship at Beth Israel Deaconess Medical Center/Harvard Medical School, contributing to neurology and hematology-oncology research. Her extensive clinical training includes externships and observerships at esteemed hospitals such as Columbia University Irving Medical Center, Duke University, and the University of Cincinnati Medical Center.

Research Interest ๐Ÿ”ฌ

Dr. Naz’s research interests encompass a broad spectrum of medical fields, including oncology, cardiology, gastroenterology, and neurology. She has made significant contributions to the study of racial disparities in clinical outcomes, stroke interventions, cardiovascular diseases, and immune-related adverse events in cancer therapy. Her work in systematic reviews and meta-analyses has provided valuable insights into improving patient care and treatment strategies.

Awards & Honors ๐Ÿ†

Dr. Naz’s dedication to research excellence has been recognized through numerous prestigious awards, including:

  • Paul Dudley White International Scholar Award (AHA, 2022) โ€“ Recognizing her impactful research in advancing clinical outcomes.
  • Cureus Medical Journal Laureate Award (2022) โ€“ Honoring her contributions to scientific knowledge and clinical education.
  • Expertscape Award for Excellence (2021) โ€“ Ranking her among the top 1% of global medical experts.
  • Distinguished Medical House Officer Award (2019) โ€“ Acknowledging her leadership in community health services.
  • BIDMC/Harvard Medical School Poster Presentation Award (2022) โ€“ Recognizing her innovation in medical research.

Publications ๐Ÿ“š

Dr. Naz has authored numerous peer-reviewed journal articles and abstracts in high-impact medical journals. Some of her key publications include:

“COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review”

Year: 2021
Citations: 50

“Psychological Stress as a Risk Factor for Cardiovascular Disease: A Case-Control Study”

Year: 2020
Citations: 47

“Meningitis as an Initial Presentation of COVID-19: A Case Report”

Year: 2020
Citations: 43

“Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review”

Year: 2022
Citations: 39

“einfection of COVID-19 in Pakistan: A First Case Report”

Year: 2020
Citations: 31

“Causes of Acute Peritonitis and Its Complication”

Year: 2021
Citations: 28

“Hypovitaminosis D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis”

Year: 2022
Citations: 27

“Association Between Hypertension and Hearing Loss”

Year: 2021
Citations: 25

“Comparison of Lipid Profile in Patients With and Without Subclinical Hypothyroidism”

Year: 2021
Citations: 25

“Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome”

Year: 2021
Citations: 19

“SGLT2 Inhibitors Among Patients With Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials”

Year: 2023
Citations: 18

“COVID-19-Induced Mesenteric Thrombosis”

Year: 2021
Citations: 17

Conclusion ๐ŸŽ‰

Dr. Sidra Naz is an exceptional candidate for the Best Researcher Award, given her strong research background, high-impact publications, and international recognition. While she could further strengthen her profile by securing independent research grants and leading more first-author studies, her diverse contributions to medical science and global health make her a highly competitive nominee.

 

 

Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award

Dr. Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award

Assistant Specialist at University of California Irvine Medical Center, United States

Dr. Fatemeh Tajik is an accomplished medical researcher dedicated to advancing cancer diagnostics. She earned her MD in 2021, ranking among the top 1% of her class. Since then, she has been engaged in groundbreaking research on cancer biomarkers, particularly circulating extracellular vesicle biomarkers for peritoneal carcinomatosis. Currently serving as an Assistant Specialist at the University of California, Irvine, Dr. Tajik contributes significantly to translational and clinical research, with the goal of improving patient outcomes.

Profile

ORCID

Education ๐ŸŽ“

Dr. Tajik completed her Doctor of Medicine (MD) in 2021. Her academic excellence placed her among the top 1% of her graduating class. Her advanced studies and research focus on cancer biomarker identification, leading to significant contributions in oncology.

Experience ๐ŸŒŸ

From 2021 to 2023, Dr. Tajik dedicated her research to identifying novel cancer biomarkers, culminating in multiple peer-reviewed publications. In 2023, she joined the Department of Surgery at the University of California, Irvine, where she specializes in translational cancer research. Additionally, she serves as a reviewer for esteemed journals and has co-authored a book chapter, further demonstrating her expertise and commitment to the field.

Research Interests ๐ŸŒฟ

Dr. Tajikโ€™s research revolves around cancer biology, with a specific focus on:

  • Cancer biomarkers
  • Extracellular vesicles
  • Peritoneal carcinomatosis Her work aims to refine predictive and prognostic tools for cancer, significantly impacting early detection and treatment approaches.

Awards ๐Ÿ†

Dr. Tajik has been recognized for her contributions to cancer research and innovation. She has been nominated for prestigious awards such as the Excellence in Research Award and the Best Researcher Award, highlighting her significant impact on the field.

Publications ๐Ÿ“š

Dr. Tajik has published extensively in high-impact journals. Her notable publications include:

“Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis”

  • Journal: Cancers
  • Publication Date: January 17, 2025
  • DOI: 10.3390/cancers17020289

“Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease”

  • Journal: Journal of Gastrointestinal Cancer
  • Publication Date: June 2024
  • DOI: 10.1007/s12029-023-00994-5

“Transformation of Chronic Lymphocytic Leukemia into Acute Mixed Phenotype Leukemia Myeloid/T Neoplasm: a Case Report”

  • Journal: SN Comprehensive Clinical Medicine
  • Publication Date: September 11, 2023
  • DOI: 10.1007/s42399-023-01567-0

“Anxiety during the COVID-19 pandemic in hospital staff: systematic review plus meta-analysis”

  • Journal: BMJ Supportive & Palliative Care
  • Publication Date: June 2023
  • DOI: 10.1136/bmjspcare-2021-003125

“A comprehensive Examination of the potential application of Chat GPT in Higher Education Institutions”

  • Type: Preprint
  • Publication Date: April 12, 2023
  • DOI: 10.36227/techrxiv.22589497.v1

“Post-COVID-19 rhinocerebral mucormycosis, a life-threatening event in the background of immunosuppressive condition: A case report”

  • Type: Preprint
  • Publication Date: January 27, 2023
  • DOI: 10.21203/rs.3.rs-2516078/v1

“Adoption of cytoreductive surgery in the management of peritoneal malignanciesโ€”Global trends”

  • Journal: Journal of Surgical Oncology
  • Publication Date: 2023
  • DOI: 10.1002/jso.27448

“Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis”

  • Journal: Cancer Cell International
  • Publication Date: 2023
  • DOI: 10.1186/s12935-023-02851-8

“Clinical significance of CD166 and HER-2 in different types of gastric cancer”

  • Journal: Clinical and Translational Oncology
  • Publication Date: 2023
  • DOI: 10.1007/s12094-023-03297-0

“COVID-19 pandemic impact on screening and diagnosis of prostate cancer: a systematic review”

  • Journal: BMJ Supportive and Palliative Care
  • Publication Date: 2023
  • DOI: 10.1136/spcare-2023-004310

Conclusion ๐Ÿ…

Fatemeh Tajik is a highly qualified candidate for the Research for Cancer Biophotonics Award due to her impressive research output, strong academic background, and impactful work in cancer diagnostics. However, to make her application more competitive, she should highlight her direct contributions to biophotonics, expand her involvement in industry collaborations, and clearly outline her most significant scientific innovations.